BOSTON & MONTREAL, December 30, 2024--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage genetic medicines company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback